Changhai Hospital

This study tests a new approach to treat high-risk bladder cancer without removing the bladder. The treatment involves freezing the tumor during surgery, followed by immunotherapy and low-dose chemotherapy. The goal is to see if this combination can improve survival and quality o…

This study tests whether adding an immunotherapy drug (toripalimab) to standard BCG treatment can help prevent bladder cancer from coming back after surgery. It involves 31 adults with high-risk non-muscle-invasive bladder cancer who have not had BCG before. The goal is to see if…

This study tests a new treatment for people with advanced pancreatic cancer whose tumors have a specific genetic change (KRAS G12V) and a certain immune type (HLA-A*11:01). The treatment uses the patient's own immune cells, modified in a lab to recognize and attack cancer cells. …

This study tests whether a lower dose (50 mg) of rectal indomethacin works as well as the standard dose (100 mg) to prevent pancreatitis after an ERCP procedure. About 1,366 adults scheduled for ERCP will be randomly assigned to receive either the low or standard dose 30 minutes …

This study tests whether giving extra fluids through a vein along with a standard anti-inflammatory drug (indometacin) can better prevent pancreatitis after a procedure that uses shock waves to break up pancreatic stones. About 1,250 adults with painful chronic pancreatitis will …

This study is gathering images from special cameras and CT scans, along with lab results, to create a database for early upper gastrointestinal cancer and precancerous conditions. About 500 adults who are already scheduled for certain procedures will take part. The goal is to imp…